c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells

Cell

Volumn 151, Issue 1, 2012, Pages 68-79

  Nie, Zuqin ^a   Hu, Gangqing ^b   Wei, Gang ^b   Cui, Kairong ^b   Yamane, Arito ^c   Resch, Wolfgang ^c   Wang, Ruoning ^d   Green, Douglas R ^d   Tessarollo, Lino ^e   Casellas, Rafael ^c   Zhao, Keji ^b   Levens, David ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE; MYC PROTEIN;

ANIMAL; ARTICLE; B LYMPHOCYTE; CYTOLOGY; EMBRYONIC STEM CELL; GENOME; HUMAN; LYMPHOCYTE; METABOLISM; MOUSE; PROMOTER REGION; SPLEEN; TRANSCRIPTION INITIATION;

ANIMALS; B-LYMPHOCYTES; DNA-DIRECTED RNA POLYMERASES; EMBRYONIC STEM CELLS; GENOME; HUMANS; LYMPHOCYTES; MICE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; SPLEEN; TRANSCRIPTIONAL ACTIVATION;

MLCS; MLOWN;

EID: 84867010006     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2012.08.033     Document Type: Article

References (65)

1. Agrawal, P., Yu, K., Salomon, A.R., Sedivy, J.M., Proteomic profiling of Myc-associated proteins. Cell Cycle 9 (2010), 4908–4921.
2. Alon, U., An introduction to systems biology: design principles of biological circuits. 2007, Chapman & Hall/CRC, Boca Raton, FL.
3. Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, I., Zhao, K., High-resolution profiling of histone methylations in the human genome. Cell 129 (2007), 823–837.
4. Beer, S., Zetterberg, A., Ihrie, R.A., McTaggart, R.A., Yang, Q., Bradon, N., Arvanitis, C., Attardi, L.D., Feng, S., Ruebner, B., et al. Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol., 2, 2004, e332.
5. Berns, K., Hijmans, E.M., Koh, E., Daley, G.Q., Bernards, R., A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts. Oncogene 19 (2000), 3330–3334.
6. Bui, T.V., Mendell, J.T., Myc: Maestro of MicroRNAs. Genes Cancer 1 (2010), 568–575.
7. Chen, X., Xu, H., Yuan, P., Fang, F., Huss, M., Vega, V.B., Wong, E., Orlov, Y.L., Zhang, W., Jiang, J., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133 (2008), 1106–1117.
8. Cheng, S.W., Davies, K.P., Yung, E., Beltran, R.J., Yu, J., Kalpana, G.V., c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat. Genet. 22 (1999), 102–105.
9. Chepelev, I., Wei, G., Tang, Q., Zhao, K., Detection of single nucleotide variations in expressed exons of the human genome using RNA-Seq. Nucleic Acids Res., 37, 2009, e106.
10. Chu, V.T., Gottardo, R., Raftery, A.E., Bumgarner, R.E., Yeung, K.Y., MeV+R: using MeV as a graphical user interface for Bioconductor applications in microarray analysis. Genome Biol., 9, 2008, R118.
11. Chung, H.J., Levens, D., c-myc expression: keep the noise down!. Mol. Cells 20 (2005), 157–166.
12. Cowling, V.H., Cole, M.D., Mechanism of transcriptional activation by the Myc oncoproteins. Semin. Cancer Biol. 16 (2006), 242–252.
13. Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W., Steine, E.J., Hanna, J., Lodato, M.A., Frampton, G.M., Sharp, P.A., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 107 (2010), 21931–21936.
14. Dang, C.V., Enigmatic MYC Conducts an Unfolding Systems Biology Symphony. Genes Cancer 1 (2010), 526–531.
15. de Alboran, I.M., O'Hagan, R.C., Gärtner, F., Malynn, B., Davidson, L., Rickert, R., Rajewsky, K., DePinho, R.A., Alt, F.W., Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14 (2001), 45–55.
16. Dmitrovsky, E., Kuehl, W.M., Hollis, G.F., Kirsch, I.R., Bender, T.P., Segal, S., Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature 322 (1986), 748–750.
17. Dominguez-Sola, D., Ying, C.Y., Grandori, C., Ruggiero, L., Chen, B., Li, M., Galloway, D.A., Gu, W., Gautier, J., Dalla-Favera, R., Non-transcriptional control of DNA replication by c-Myc. Nature 448 (2007), 445–451.
18. Eberhardy, S.R., Farnham, P.J., Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J. Biol. Chem. 277 (2002), 40156–40162.
19. Eilers, M., Eisenman, R.N., Myc's broad reach. Genes Dev. 22 (2008), 2755–2766.
20. Felton-Edkins, Z.A., Kenneth, N.S., Brown, T.R., Daly, N.L., Gomez-Roman, N., Grandori, C., Eisenman, R.N., White, R.J., Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc. Cell Cycle 2 (2003), 181–184.
21. Grandori, C., Gomez-Roman, N., Felton-Edkins, Z.A., Ngouenet, C., Galloway, D.A., Eisenman, R.N., White, R.J., c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat. Cell Biol. 7 (2005), 311–318.
22. Hann, S.R., Eisenman, R.N., Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4 (1984), 2486–2497.
23. Herkert, B., Eilers, M., Transcriptional repression: the dark side of myc. Genes Cancer 1 (2010), 580–586.
24. Herschlag, D., Johnson, F.B., Synergism in transcriptional activation: a kinetic view. Genes Dev. 7 (1993), 173–179.
25. Huang, C.Y., Bredemeyer, A.L., Walker, L.M., Bassing, C.H., Sleckman, B.P., Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse. Eur. J. Immunol. 38 (2008), 342–349.
26. Ingolia, N.T., Lareau, L.F., Weissman, J.S., Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147 (2011), 789–802.
27. James, L., Eisenman, R.N., Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo. Proc. Natl. Acad. Sci. USA 99 (2002), 10429–10434.
28. Ji, H., Wu, G., Zhan, X., Nolan, A., Koh, C., De Marzo, A., Doan, H.M., Fan, J., Cheadle, C., Fallahi, M., et al. Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation. PLoS ONE, 6, 2011, e26057.
29. Kelly, K., Cochran, B.H., Stiles, C.D., Leder, P., Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35 (1983), 603–610.
30. Kuchen, S., Resch, W., Yamane, A., Kuo, N., Li, Z., Chakraborty, T., Wei, L., Laurence, A., Yasuda, T., Peng, S., et al. Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 32 (2010), 828–839.
31. Land, H., Parada, L.F., Weinberg, R.A., Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304 (1983), 596–602.
32. Langmead, B., Schatz, M.C., Lin, J., Pop, M., Salzberg, S.L., Searching for SNPs with cloud computing. Genome Biol., 10, 2009, R134.
33. Levens, D., You Don't Muck with MYC. Genes Cancer 1 (2010), 547–554.
34. Li, Z., Van Calcar, S., Qu, C., Cavenee, W.K., Zhang, M.Q., Ren, B., A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. USA 100 (2003), 8164–8169.
35. Lin, C.Y., Lovén, J., Rahl, P.B., Paranal, R.M., Burge, C.B., Bradner, J.E., Lee, T.I., Young, R.A., Transcriptional Amplification in Tumor Cells with Elevated c-Myc. Cell 151 (2012), 56–67 this issue.
36. Liu, J., Levens, D., Making myc. Curr. Top. Microbiol. Immunol. 302 (2006), 1–32.
37. Margolin, A.A., Palomero, T., Sumazin, P., Califano, A., Ferrando, A.A., Stolovitzky, G., ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes. Proc. Natl. Acad. Sci. USA 106 (2009), 244–249.
38. Mehmet, H., Littlewood, T.D., Sinnett-Smith, J., Moore, J.P., Evan, G.I., Rozengurt, E., Large induction of c-Myc is not essential for the mitogenic response of Swiss 3T3 fibroblasts. Cell Growth Differ. 8 (1997), 187–193.
39. Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.K., Koche, R.P., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 (2007), 553–560.
40. Muse, G.W., Gilchrist, D.A., Nechaev, S., Shah, R., Parker, J.S., Grissom, S.F., Zeitlinger, J., Adelman, K., RNA polymerase is poised for activation across the genome. Nat. Genet. 39 (2007), 1507–1511.
41. Nepveu, A., Marcu, K.B., Skoultchi, A.I., Lachman, H.M., Contributions of transcriptional and post-transcriptional mechanisms to the regulation of c-myc expression in mouse erythroleukemia cells. Genes Dev. 1 (1987), 938–945.
42. Nikiforov, M.A., Chandriani, S., O'Connell, B., Petrenko, O., Kotenko, I., Beavis, A., Sedivy, J.M., Cole, M.D., A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol. Cell. Biol. 22 (2002), 5793–5800.
43. Poser, I., Sarov, M., Hutchins, J.R., Hériché, J.K., Toyoda, Y., Pozniakovsky, A., Weigl, D., Nitzsche, A., Hegemann, B., Bird, A.W., et al. BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals. Nat. Methods 5 (2008), 409–415.
44. Rabbitts, P.H., Watson, J.V., Lamond, A., Forster, A., Stinson, M.A., Evan, G., Fischer, W., Atherton, E., Sheppard, R., Rabbitts, T.H., Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J. 4 (1985), 2009–2015.
45. Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A., Wysocka, J., A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470 (2011), 279–283.
46. Rahl, P.B., Lin, C.Y., Seila, A.C., Flynn, R.A., McCuine, S., Burge, C.B., Sharp, P.A., Young, R.A., c-Myc regulates transcriptional pause release. Cell 141 (2010), 432–445.
47. Sampson, V.B., Rong, N.H., Han, J., Yang, Q., Aris, V., Soteropoulos, P., Petrelli, N.J., Dunn, S.P., Krueger, L.J., MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 67 (2007), 9762–9770.
48. Shaffer, A.L., Wright, G., Yang, L., Powell, J., Ngo, V., Lamy, L., Lam, L.T., Davis, R.E., Staudt, L.M., A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol. Rev. 210 (2006), 67–85.
49. Sharma, S.V., Gajowniczek, P., Way, I.P., Lee, D.Y., Jiang, J., Yuza, Y., Classon, M., Haber, D.A., Settleman, J., A common signaling cascade may underlie “addiction” to the Src, BCR-ABL, and EGF receptor oncogenes. Cancer Cell 10 (2006), 425–435.
50. Thomas, L.R., Tansey, W.P., Proteolytic control of the oncoprotein transcription factor Myc. Adv. Cancer Res. 110 (2011), 77–106.
51. Tonini, G.P., Radzioch, D., Gronberg, A., Clayton, M., Blasi, E., Benetton, G., Varesio, L., Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562. Cancer Res. 47 (1987), 4544–4547.
52. Wang, H., Hammoudeh, D.I., Follis, A.V., Reese, B.E., Lazo, J.S., Metallo, S.J., Prochownik, E.V., Improved low molecular weight Myc-Max inhibitors. Mol. Cancer Ther. 6 (2007), 2399–2408.
53. Wang, R., Dillon, C.P., Shi, L.Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L.L., Fitzgerald, P., Chi, H., Munger, J., Green, D.R., The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35 (2011), 871–882.
54. Wasylishen, A.R., Penn, L.Z., Myc: the beauty and the beast. Genes Cancer 1 (2010), 532–541.
55. Wettenhall, J.M., Simpson, K.M., Satterley, K., Smyth, G.K., affylmGUI: a graphical user interface for linear modeling of single channel microarray data. Bioinformatics 22 (2006), 897–899.
56. Wierstra, I., Alves, J., The c-myc promoter: still MysterY and challenge. Adv. Cancer Res. 99 (2008), 113–333.
57. Yamane, A., Resch, W., Kuo, N., Kuchen, S., Li, Z., Sun, H.W., Robbiani, D.F., McBride, K., Nussenzweig, M.C., Casellas, R., Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat. Immunol. 12 (2011), 62–69.
58. Zang, C., Schones, D.E., Zeng, C., Cui, K., Zhao, K., Peng, W., A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics 25 (2009), 1952–1958.
59. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W., Liu, X.S., Model-based analysis of ChIP-Seq (MACS). Genome Biol., 9, 2008, R137.
60. Bailey, T.L., Williams, N., Misleh, C., and Li, W.W. (2006). MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Res. 34 (Web Server issue), W369–W373.
61. El-Naggar, A.K. (2004). Concurrent flow cytometric analysis of DNA and RNA. Methods Mol. Biol. 263, 371–384.
62. Liu, P., Jenkins, N.A., and Copeland, N.G. (2003). A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res. 13, 476–484.
63. Parkin, N., Darveau, A., Nicholson, R., and Sonenberg, N. (1988). cis-acting translational effects of the 5′ noncoding region of c-myc mRNA. Mol. Cell. Biol. 8, 2875–2883.
64. Reid, S.W., and Tessarollo, L. (2009). Isolation, microinjection and transfer of mouse blastocysts. Methods Mol. Biol. 530, 269–285.
65. Southon, E., and Tessarollo, L. (2009). Manipulating mouse embryonic stem cells. Methods Mol. Biol. 530, 165–185.